![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Asociación para Evitar la Ceguera en México |
Information provided by: | Asociación para Evitar la Ceguera en México |
ClinicalTrials.gov Identifier: | NCT00418431 |
Central serous chorioretinopathy (CSC) has been known since it was first described by Von Graefe and termed “idiopathic detachment of the macula” in 1866, is a well-characterized disorder leading to serous neurosensory elevation of the central macula. The acute form of the disease is associated with focal leakage at the level of the retinal pigment epithelium (RPE) demonstrated with fluorescein angiography (FA). The disorder is self-limited in the majority of patients, who also regain excellent vision. Occasionally, the neurosensory detachment persists and leads to pigment epithelial and photoreceptor damage with visual impairment.
The purpose of this clinical study is report the use of intravitreal bevacizumab is a new option in the treatment of the chronic or recurrent CSC.
Condition | Intervention | Phase |
Central Serous Chorioretinopathy |
Drug: Intravitreal injection of Bevacizumab |
Phase II Phase III |
ChemIDplus related topics: | Bevacizumab |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Ages Eligible for Study: | 20 Years to 50 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria
Contact: Mitzy E Torres Soriano, MD | 525510841400 ext 1172 | retinamex@yahoo.com |
Contact: Hugo Quiroz-Mercado, MD | 525510841400 ext 1171 | hugoquiroz@yahoo.com |
Mexico, DF | |||||
Asociacion para Evitar la Ceguera en Mexico | Recruiting | ||||
Mexico DF, DF, Mexico, 04030 | |||||
Contact: Mitzy E Torres Soriano, MD 5255510841400 ext 1171 mitzytorres@yahoo.com | |||||
Sub-Investigator: Maura Abraham, MD | |||||
Sub-Investigator: Orlando Ustariz, MD | |||||
Sub-Investigator: Gerardo Garcia Aguirre | |||||
Sub-Investigator: Veronica Kon-Jara, MD | |||||
Sub-Investigator: Hugo Quiroz-Mercado, MD | |||||
Sub-Investigator: Jose L Guerrero, MD |
Asociación para Evitar la Ceguera en México |
Principal Investigator: | Mitzy E Torres Soriano, MD | APEC |
Study ID Numbers: | APEC-0016 |
First Received: | January 3, 2007 |
Last Updated: | January 3, 2007 |
ClinicalTrials.gov Identifier: | NCT00418431 |
Health Authority: | MEXICO : SECRETARIA DE SALUD |
|
|
|
![]() |